Application

PTO Form 1478 (Rev 9/2006)

OMB No. 0651-0009 (Exp 12/31/2014)

---

PTO Form 1478 (Rev 9/2006)

OMB No. 0651-0009 (Exp 12/31/2014)

Trademark/Service Mark Application, Principal Register

Serial Number: 85708911

Filing Date: 08/21/2012

To the Commissioner for Trademarks:

MARK: ABREVA (stylized and/or with design, see mark)

The literal element of the mark consists of ABREVA.
The applicant is not claiming color as a feature of the mark. The mark consists of ABREVA in stylized lowercase letters.
The applicant, SmithKline Beecham (Cork) Limited, a corporation of Ireland, having an address of
      Currabinny, Carrigaline
      County Cork
      Ireland


requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations, namely, anti-viral preparations for cold sores and fever blisters; adhesive bandages; self-adhesive dressings

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 06/01/2006, and first used in commerce at least as early as 06/01/2006, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods and/or services, consisting of a(n) photograph of packaging.
Specimen File1



The applicant claims ownership of U.S. Registration Number(s) 2464248, 3095511, and 3303747.

The applicant's current Attorney Information:
      Terence A. Dixon and Maribeth Day Case, Diane F. Maginnis, Christopher Hanes of GlaxoSmithKline

      LGTM - FP2030
      One Franklin Plaza,200 North 16th Street
      Philadelphia, Pennsylvania 19102
      United States
The attorney docket/reference number is TMR5086385/011/KMG.

The applicant hereby appoints Terence A. Dixon of GlaxoSmithKline
      LGTM - FP2030
      One Franklin Plaza,200 North 16th Street
      Philadelphia Pennsylvania 19102
      United States
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The applicant's current Correspondence Information:

Terence A. Dixon

GlaxoSmithKline

LGTM - FP2030       One Franklin Plaza,200 North 16th Street

Philadelphia, Pennsylvania 19102

215-751-7653(phone)

215-751-7066(fax)

trademarks@gsk.com (authorized)

A fee payment in the amount of $325 has been submitted with the application, representing payment for 1 class(es).

Declaration

The undersigned, being hereby warned that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements, and the like, may jeopardize the validity of the application or any resulting registration, declares that he/she is properly authorized to execute this application on behalf of the applicant; he/she believes the applicant to be the owner of the trademark/service mark sought to be registered, or, if the application is being filed under 15 U.S.C. Section 1051(b), he/she believes applicant to be entitled to use such mark in commerce; to the best of his/her knowledge and belief no other person, firm, corporation, or association has the right to use the mark in commerce, either in the identical form thereof or in such near resemblance thereto as to be likely, when used on or in connection with the goods/services of such other person, to cause confusion, or to cause mistake, or to deceive; and that all statements made of his/her own knowledge are true; and that all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /tad/   Date: 08/21/2012
Signatory's Name: Terence A. Dixon
Signatory's Position: Attorney of Record (Member of New York and Pennsylvania bars)
RAM Sale Number: 868
RAM Accounting Date: 08/22/2012

Serial Number: 85708911
Internet Transmission Date: Tue Aug 21 14:29:55 EDT 2012
TEAS Stamp: USPTO/BAS-XXX.XX.XX.X-201208211429553417
14-85708911-4908669181c719d6721948a7f98b
629b7-DA-868-20120821130714537692